[CCoE Notice] New York State of Neuro

Tue Nov 17 09:53:17 CST 2020

Dearn Faculty and Students,

Please review the below opportunity. Email egrrsrch at uh.edu<mailto:egrrsrch at uh.edu> if you are interested in applying or need any assistance.

Thank you.

From: Johnson & Johnson Innovation <jji at jnjinnovation.com>
Reply-To: "jji at jnjinnovation.com" <jji at jnjinnovation.com>
Date: Monday, November 16, 2020 at 7:04 PM
To: "sgghurye2 at uh.edu" <sgghurye2 at uh.edu>
Subject: New York State of Neuro

Neuroscience visionaries: Submit ideas for pioneering innovations

Neuroscience visionaries: Submit ideas for pioneering innovations

Images missing? View this email as a web page here<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VX9kDG41nm6PW3CF4gt3X9p4kW842MfZ4jv28RN4Hzmfm5nxHkV3Zsc37CgKp5W8RTdk173YnH_VmvdVq8762CwW6RPtdF4Gxq3jW3TpR-b3SgBmbVNx-R97fBTXLW4jYBHM2D9R5zW5CqZ2N84fK5qW6y80mr70tV3hW7fgtTw4mX4w_W2BW57R98r17BW85Pry33R5grfW79V8jv6g-cvzW8KnLVN3jy7xtW2bmM-y1DGl0bV8FdVN6KPXbgN5TK5WG4sVtwW4GJ36R8ChVnSW54BjVh91pYFcW86_8Gd53lPs7W6V66yc3m30tMW94TXKB15QWTYW5WjjMv5zFFljW3Dz6vp5D_BtDW8LTXYg2ZjZjjVvMtVy1kWhkSVpCXp36Zn7vbW10nWbg5YPhqDVS1cDw485mxkW1p8Ly07vNxRdN2gd7B4X3hFxW3lMLKh79wXvkW1SNK_79cp9nrW7D8rGh2rP91DV77H6T1RWq6LW7_SlyT2K97xGW1kd5cK16RGp3MwgYX9YWW7kW1q2XNV1h9z7SM-0k5FJc3ByW4xr74p2kkV7t32hH1__;!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0EJrHpV3$>.

[jnj_innovation_new_red]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VX9kDG41nm6PW3CF4gt3X9p4kW842MfZ4jv28RN4HzmfG3p_9rV1-WJV7CgWhyVW8DBZ69NHM5W4BnZSq5jp8dZW21r5lQ9l5v-jN8z6rQvRd99NW5cjPcY7lYV-pW8vW1yh3Ht2tTN6rCFCVfRlQnW3V_p6f3YClL-W11N0ZP30f78bW5-jX0c3JjMHZW1XgH3W2DXLxmW4vM-BL6GQnvxN1DK14J466XPW3dj371591z2DW6d8YR84J-H7JW3Vtyw_8xmfR8W4sY1HM1NpVJQW4DGyy-79q8TlW9cslYX7m-PtNVshLK-1yWqlbW8KcpTP3Sr90JW2z2X8J9cFpxzW6cyX_R8hkw8tW15Qymt5bySmqW5_VvjV35mgPkW8_LZVh98QPf537-L1__;!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0GNkoZpr$>

QUICKFIRE CHALLENGE BRIEF

[neuroscience_qfc_2]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VX9kDG41nm6PW3CF4gt3X9p4kW842MfZ4jv28RN4Hzmd95nxG7V3Zsc37CgVy4W58nDhM1st3kjW3thYBV1VgrL_W1-FzrN247bZNW2H8gsj7rHPKSW8lnGBL1Q9ktNN4-j-pzJkwZYW2g56ZY3t7CrrW65QcbX5sZ59dW7ZLVS43bBVrcW1X8nCx1hqZNvW4b564w1zM9R4W3NLryT7vg0v9W2DmnTz75KwjtW5jKzWR59vVT5W37DDPQ1Y09jwW7pnNXj5Gk5Z_W2xl8MP4llmfhW5ydb3b5ZvphwW3WfZ2L44206tW4QGXD536zcrvW4Kzv1l1TR80lVs62YC3K572XW1b17gm1TYxVbW86Cx-11-_4cYVSs_C_7RDsqGW41F-mD8-mgwSW2YF9TY87kBL3N8vNchMMnGHXM7xFDDHFpGHW95VC5d4svVFSW8Y-whb7l4R5FN7PDCzC3XrDG39H51__;!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0FsuB-Fg$>

NYC INNOVATION QUICKFIRE CHALLENGE ON NEUROSCIENCE

[Enter the challenge]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VX9kDG41nm6PW3CF4gt3X9p4kW842MfZ4jv28RN4Hzmd97SKxDV5X_Kf7CgVxnW8vrC-5616Mz-W7kKfVd5qgh5DW1JSh523WZ_fVW5qsf545Rk6W_VwV5wm2b3R6_W4Lz6KG5gQPWlN4Mz7-BXrhsfW1N0XTk3jVNTwW6fwS7K7BNGsvW2cgnhG4SSqCBV3kXNV4mQGkbW5cGcW68qLZXwVC8L1n3q_8n6W47B7LQ1kT00CW79T2D_7JZ89tW644dT_1MhSB1W1MjXTN7Bx33lW70sr8B2Cq6sXVwHVtc4kY_bgW5Sc4f14DGB8SN2B3NX9kTQfvV3WZy_5lRxQ7W5QhJ7N4qnMNYW796ddb1L4kh9W332Km_3x5n10TXXk-2bn6G5W4ZZ-t699W8TCW5g5pYS8f5H0vW132XCq1ZBdTJW1lgx5M6PH-mVW5mX63468yv9kVlnRjG3tBXdNW4YZdNQ6sDLM1W1DY10479b6K7W2f1wYC1s-tszVX55ZG3kn013W3qRlBR8jrd5LVMz5GS94xPRzVK5FKQ5YGrrrF5R_fJbBcN4W93J0Hs2G2m06N1cNwhFHPTPGW8N2yQq1D1HHCW4tG3pC3y_YhNW10VRmv7g5PKjW883SJF8VR0sMVx50T55h4B7kW8K65q845nddg3fgY1__;!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0Ngo-Nua$>

Submission deadline: February 12, 2021

Dear Shilpa,

Johnson & Johnson Innovation invites groundbreakers to submit ideas aimed at reducing the burden and disability caused by serious neuropsychiatric, neurological and neurodegenerative diseases in the NYC Innovation QuickFire Challenge on Neuroscience.

Areas of interest

We encourage applications from neuroscience groundbreakers working on projects related to target identification, target validation or measurements that help patient selection or treatment response to support the discovery and development of breakthrough therapies for neuropsychiatric, neurological and neurodegenerative diseases, with a particular interest in the following areas:

  *   Neuropsychiatric diseases, including behavioral domains (e.g. anhedonia, anxiety and sleep) that are commonly dysregulated in serious mental illnesses.
  *   Neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and ALS using small molecule approaches as well as alternative modalities (e.g. gene therapy, ASO and siRNA).
  *   Approaches that advance understanding of neuroimmunology with potential to create new therapeutic avenues to modulate neuroinflammation.
  *   Digital biomarkers and therapeutics to improve patient outcomes and support precision central nervous system medicine approaches.

Rewards and benefits

  *   Up to US$25,000 in grant funding
  *   One year of residency at JLABS @ NYC - with the use of a bench, workstation and access to the JLABS @ NYC community
  *   Mentorship from leadership from the Johnson & Johnson Family of Companies

Don't miss out!

[Enter the challenge]<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VX9kDG41nm6PW3CF4gt3X9p4kW842MfZ4jv28RN4Hzmd97SKxDV5X_Kf7CgJ6MW3QhZzc6cT9ktW526yVV12G6GwW33-tBg4Cq7XKW3t0VBc6pyDQ1N4bYQKrNqVltW8Bh66x46db4kN6LljJ4YgqwnW7tf2rf4-jx8PW3xZnT04lYxlpW7VbDNk4w6mkfW2n960177wLSRW3FkcKX4XJPJdW5y9t0d43SqD3N8MCP3dx95NYW5T-l012RS1SxW2xFvzS31bQqJW6L4C8h2JKPtFW3f1RDw8rXBLgW48xwm95SP-KkW3Z0rBx1Jff_jW6fP91q3cCP_kW4s3hmw8B_rqPW3119gK3jwJCGW4_DWsh82MJk-W7t8kYH6_VvzbVGcwHQ7yZQW5W2d7RrH1H3qb3W2gJk446mmWm6W4HnMqh90MXqMW3TwZGZ7KPpQCW5qHbF026s7H3W46fnJd8-cYPrW7pzvfz7yYRsYW7LXHkW2PHwcnW4ZhVy27hMV1FN8Zqvb36hMN6N14pBFqrRMnHW1HMjrN2mpMlzW6bGnwB3frxTBW90tr2L1Wm2LzW7YK8FQ4ZVQgxVZXMlc6rmhfzW2-D7Ny7n_sWdW1gl8T76CtZnVW9lpRsW68pD_KW6g653M4jNXHKW9m1RVZ47GxxtV7XDjP36d-CN390b1__;!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0KcaIV2-$>

Submission deadline: February 12, 2021

© Johnson & Johnson Innovation 2020.

This email is from Johnson &amp; Johnson Innovation and represents a selection of activities from across our Innovation Centers, JLABS and JJDC. The information in this email is for informational purposes only. The information is either proprietary or licensed to Johnson &amp; Johnson Innovation LLC, its parent company or any affiliate companies ("JJI") or is provided by or proprietary to third parties. In case of third party information, please note that only those third parties that provided or own this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in this email. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of JJI, Johnson &amp; Johnson or its affiliates. JJI and Johnson &amp; Johnson are not responsible or liable for any actions you do or do not take in relation to this information and are not responsible for any use of this information by you. By providing the information in this email, JJI does not make any representations, warranties, or assurances, express or implied, as to the content or the information presented in this email and is not responsible for any use by or alterations of this information by you. JJI hereby expressly disclaims any and all guarantees, representations, warranties, or assurances and assumes no responsibility or liability, direct or indirect in relation to the information in this email.

Johnson & Johnson Innovation | 1 Johnson & Johnson Plaza | New Brunswick, NJ  08901 | USA
You received this email because you are subscribed to QuickFire Challenges Brief from Johnson & Johnson Innovation.
Update your profile<https://urldefense.com/v3/__https:/h8.t.hubspotemail.net/e2t/tc/VX9kDG41nm6PW3CF4gt3X9p4kW842MfZ4jv28RN4HzmfZ3p_9LV1-WJV7CgJB6W2BDN9g78PCrfW3D4ZRK5CvVcvW4vwfYf1jLqNmW3sJSmh7qBG6DN6QvbWZWcT6cW8sN1F83Xfgd2W1YChjt5tm4KMW4Fq6R42dFCklW600Lc77gCdm9W2fP9Qy1sp85tW23TlT_3k8STGVyZL5P6Tcj4RW8D-gFV4Cnj9MW57TV_G72THr0V9fN7c6BQDJGW6FGLdT2llySXV6H9vL7RfLN2W4g1dqn3MRV4KW7BYV6q6B8rl7W4mqgmq88q6jKW5CMBP429Ms6HW7LpsTl1psdBQW2rscNc5r4g82W8_rXxF363s1sW2j6rcx35MDHzW5m62NT82R_Q_W3hxRBm8-WDK2N2qTwzG57_SQ3l931__;!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0P-qVpJ_$> to choose the types of emails you receive, or unsubscribe from future emails<https://urldefense.com/v3/__https:/hs-3988599.s.hubspotemail.net/hs/manage-preferences/unsubscribe?d=VnbTNN6MXH38VCsNKB3R5JYDW3JH5dN3Qz74WW4h26H75DV1tyVmWFfL7rS77YN6mhk-W25z_qW8SdrC16cq0PJVWlGMl5NtR-FMXk_7Qbw0q5W9jkJLh3mgQZfW1Gp4Pm7x2qcV3gQ12&v=3&utm_campaign=NYC*20Innovation*20QFC*20on*20Neuroscience&utm_source=hs_email&utm_medium=email&utm_content=100001284&_hsenc=p2ANqtz-9xMOgeY5DimLe79G4hZKcUj7QtErBrfQa0OJtrEvkhMeL9IIaGelQh0fK52rHcPrO9_EwRW4u7rv49KQYVe71Rcz-2ew&_hsmi=100002827__;JSUlJQ!!LkSTlj0I!UISYbA8M8zxoheWD5h_NTVOtsRxC2_kNar8Wze-cX8X4UBHssblfNtMx0GJY5r5Z$>

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://Bug.EGR.UH.EDU/pipermail/engi-dist/attachments/20201117/eb3d3cc2/attachment-0001.html 